FDA approves Boehringer Ingelheim Corporation’s Mirapex for the treatment of Parkinson’s disease
- February 22, 2010
Boehringer Ingelheim Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration has approved Mirapex ER® extended-release tablets, a new once-daily treatment option for the signs and symptoms of early ... Read More